Shah Smital
SEC insider (Form 3/4/5 filer). CIK 0001808821. Chief Fin. and Bus. Officer at Lyell Immunopharma, Inc. (LYEL). 1 reported Form 4/5 transaction since Sep 2024; latest on Mar 9, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Shah Smital has filed insider reports for
- Lyell Immunopharma, Inc. (LYEL): Officer, Chief Fin. and Bus. Officer
Shah Smital
CIK: 0001808821
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LYEL
Lyell Immunopharma, Inc.
Officer